Department of Laboratory Medicine Center, Affiliated Hospital of Nantong University, Jiangsu, PR China.
Clin Biochem. 2010 May;43(7-8):655-60. doi: 10.1016/j.clinbiochem.2010.02.004. Epub 2010 Feb 18.
The objective of this study was to investigate the effect of knockdown of Livin expression on reversing drug resistance phenotype of colon cancer HCT-8/V cells.
Specific short hairpin RNA (shRNA) was chosen and transfected in human colon cancer HCT-8/V cell line. Cell apoptosis and chemosensitivity were evaluated following downregulation of Livin expression.
In the current study, Livin was found to be highly expressed in the HCT-8/V colon cancer cells, which were resistant to several anti-tumor drugs. Knocking down of Livin expression in HCT-8/V cells by specific RNAi facilitated the apoptosis of HCT-8/V cells in response to vincristine (VCR), etoposide (VP-16), and 5-flourouracil (5-FU). Chemosensitivity assay confirmed the results and demonstrated the reversal of drug resistance phenotype of HCT-8/V cells.
These data suggest that specific silencing of Livin gene expression could be a promising target for further research in clinical chemotherapy of colon cancer.
本研究旨在探讨下调 Livin 表达对逆转结肠癌 HCT-8/V 细胞耐药表型的影响。
选择特异性短发夹 RNA(shRNA)并转染人结肠癌 HCT-8/V 细胞系。下调 Livin 表达后评估细胞凋亡和化疗敏感性。
在本研究中,发现 Livin 在对多种抗肿瘤药物耐药的 HCT-8/V 结肠癌细胞中高表达。特异性 RNAi 下调 HCT-8/V 细胞中的 Livin 表达促进了 HCT-8/V 细胞对长春新碱(VCR)、依托泊苷(VP-16)和 5-氟尿嘧啶(5-FU)的凋亡。化疗敏感性试验证实了这一结果,并显示出 HCT-8/V 细胞耐药表型的逆转。
这些数据表明,特异性沉默 Livin 基因表达可能是结肠癌临床化疗进一步研究的有前途的靶点。